Article Details

Centerview grows role as go-to adviser for biopharma dealmaking

Retrieved on: 2022-11-08 22:09:31

Tags for this article:

Click the tags to see associated articles and topics

Centerview grows role as go-to adviser for biopharma dealmaking. View article details on HISWAI: https://www.biopharmadive.com/news/centerview-biotech-pharma-deals-acquisitions/635977/

Excerpt

Goldman Sachs, 29, ChemoCentryx, Turning Point, Medicines Co. J.P. Morgan, 23, Kymab, VelosBio, Aimmune. Morgan Stanley, 18, Global Blood, ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up